A
Antonio Rosato
Researcher at University of Padua
Publications - 207
Citations - 10494
Antonio Rosato is an academic researcher from University of Padua. The author has contributed to research in topics: Cytotoxic T cell & CTL*. The author has an hindex of 43, co-authored 165 publications receiving 8898 citations.
Papers
More filters
Journal ArticleDOI
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
Michelangelo Cordenonsi,Francesca Zanconato,Luca Azzolin,Mattia Forcato,Antonio Rosato,Chiara Frasson,Masafumi Inui,Marco Montagner,Anna Parenti,Alessandro Poletti,Maria Grazia Daidone,Sirio Dupont,Giuseppe Basso,Silvio Bicciato,Stefano Piccolo +14 more
TL;DR: It is shown that the activity of TAZ, a transducer of the Hippo pathway, is required to sustain self-renewal and tumor-initiation capacities in breast CSCs and reveals a mechanistic basis of the control of Hippo kinases by cell polarity.
Journal ArticleDOI
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Francesca Zanconato,Mattia Forcato,Giusy Battilana,Luca Azzolin,Erika Quaranta,Beatrice Bodega,Antonio Rosato,Silvio Bicciato,Michelangelo Cordenonsi,Stefano Piccolo +9 more
TL;DR: This work highlights a new layer of signalling integration, feeding on YAP/TAZ function at the chromatin level, which occurs almost exclusively from distal enhancers that contact target promoters through chromatin looping.
Journal ArticleDOI
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
Maddalena Adorno,Michelangelo Cordenonsi,Marco Montagner,Sirio Dupont,Christine E. Wong,Byron Hann,Aldo Solari,Sara Bobisse,Maria Rondina,Vincenza Guzzardo,Anna Parenti,Antonio Rosato,Silvio Bicciato,Allan Balmain,Stefano Piccolo +14 more
TL;DR: Two common oncogenic lesions, mutant-p53 and Ras, selected in early neoplasms to promote growth and survival, also prefigure a cellular set-up with particular metastasis proclivity by TGFbeta-dependent inhibition of p63 function.
Journal ArticleDOI
A MicroRNA targeting dicer for metastasis control.
Graziano Martello,Antonio Rosato,Francesco Ferrari,Andrea Manfrin,Michelangelo Cordenonsi,Sirio Dupont,Elena Enzo,Vincenza Guzzardo,Maria Rondina,Thomas Spruce,Anna Parenti,Maria Grazia Daidone,Silvio Bicciato,Stefano Piccolo +13 more
TL;DR: These findings suggest a new pathway by which Dicer inhibition drifts epithelial cancer toward a less-differentiated, mesenchymal fate to foster metastasis, and attenuates miRNA biosynthesis by targeting Dicer, a key component of the miRNA processing machinery.
Journal ArticleDOI
Metabolic control of YAP and TAZ by the mevalonate pathway
Giovanni Sorrentino,Naomi Ruggeri,Valeria Specchia,Michelangelo Cordenonsi,Miguel Mano,Sirio Dupont,Andrea Manfrin,Eleonora Ingallina,Roberta Sommaggio,Silvano Piazza,Antonio Rosato,Stefano Piccolo,Giannino Del Sal +12 more
TL;DR: It is shown that YAP/TAZ activity is controlled by the SREBP/mevalonate pathway, which is required for proliferation and self-renewal of breast cancer cells and reveals an additional layer of YAP-TAZ regulation by metabolic cues.